Conn’s Current Therapy 2026

Selected for the 2026 Doody’s Core Titles as an Essential Purchase in both Family Medicine and General Internal Medicine, Conn’s Current Therapy 2026 continues a 75-year legacy of delivering premier, evidence-based clinical guidance. Edited by Rick D. Kellerman and Joel J. Heidelbaugh, this indispensable resource blends the latest scientific research with the personal experience and clinical discernment of expert physicians. It provides primary care physicians, subspecialists, and allied health professionals with current, concise, and in-depth treatment information for a wide range of acute and chronic conditions.

Key Features

• Extensive Topic Updates: Nearly 350 topics have been meticulously reviewed and updated to bring you state-of-the-art content in the most rapidly changing areas of medicine.

• Expert Clinical Approaches: Offers personal approaches and clinical management options from recognized leaders covering common complaints, acute diseases, and chronic illnesses.

• Point-of-Care Format: Follows a consistent, easy-to-use format throughout, featuring diagnosis, therapy, drug protocols, and treatment pearls presented in quick-reference boxes and tables.

• Comprehensive Guidelines: Contains updated literature and guidelines for key topics such as chest pain, hypertension, GERD, diabetic ketoacidosis, Parkinson disease, anxiety, UTIs, obesity, and immunization practices.

• PharmD-Reviewed Drug Data: Provides up-to-date drug information that has been thoroughly reviewed by expert PharmDs to ensure safety and accuracy.

• Visual Management Tools: Features nearly 300 images—including algorithms, anatomical illustrations, and clinical photographs—that provide vital visual aids for patient management.